chr17-30971197-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_032322.4(RNF135):​c.124C>T​(p.Arg42Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000161 in 1,524,362 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R42H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00016 ( 0 hom. )

Consequence

RNF135
NM_032322.4 missense

Scores

5
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -0.650

Publications

0 publications found
Variant links:
Genes affected
RNF135 (HGNC:21158): (ring finger protein 135) The protein encoded by this gene contains a RING finger domain, a motif present in a variety of functionally distinct proteins and known to be involved in protein-protein and protein-DNA interactions. This gene is located in a chromosomal region known to be frequently deleted in patients with neurofibromatosis. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
RNF135 Gene-Disease associations (from GenCC):
  • overgrowth-macrocephaly-facial dysmorphism syndrome
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • overgrowth syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007810384).
BP6
Variant 17-30971197-C-T is Benign according to our data. Variant chr17-30971197-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 2343688.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=1}.
BS2
High AC in GnomAd4 at 24 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RNF135NM_032322.4 linkc.124C>T p.Arg42Cys missense_variant Exon 1 of 5 ENST00000328381.10 NP_115698.3 Q8IUD6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RNF135ENST00000328381.10 linkc.124C>T p.Arg42Cys missense_variant Exon 1 of 5 1 NM_032322.4 ENSP00000328340.5 Q8IUD6-1

Frequencies

GnomAD3 genomes
AF:
0.000158
AC:
24
AN:
152184
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00375
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000305
AC:
36
AN:
117888
AF XY:
0.000307
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00396
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000114
Gnomad OTH exome
AF:
0.000272
GnomAD4 exome
AF:
0.000161
AC:
221
AN:
1372178
Hom.:
0
Cov.:
31
AF XY:
0.000158
AC XY:
107
AN XY:
676828
show subpopulations
African (AFR)
AF:
0.0000341
AC:
1
AN:
29306
American (AMR)
AF:
0.00
AC:
0
AN:
35038
Ashkenazi Jewish (ASJ)
AF:
0.00421
AC:
104
AN:
24692
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34424
South Asian (SAS)
AF:
0.00
AC:
0
AN:
78082
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
34096
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4808
European-Non Finnish (NFE)
AF:
0.0000940
AC:
101
AN:
1074448
Other (OTH)
AF:
0.000262
AC:
15
AN:
57284
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
13
25
38
50
63
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000158
AC:
24
AN:
152184
Hom.:
0
Cov.:
33
AF XY:
0.000175
AC XY:
13
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41464
American (AMR)
AF:
0.0000654
AC:
1
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00375
AC:
13
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4838
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68000
Other (OTH)
AF:
0.000478
AC:
1
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000437
Hom.:
0
Bravo
AF:
0.000125
ExAC
AF:
0.000134
AC:
5

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jun 10, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.124C>T (p.R42C) alteration is located in exon 1 (coding exon 1) of the RNF135 gene. This alteration results from a C to T substitution at nucleotide position 124, causing the arginine (R) at amino acid position 42 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Benign:1
Feb 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RNF135: BS1, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.020
T;T;.;.
Eigen
Benign
-0.16
Eigen_PC
Benign
-0.41
FATHMM_MKL
Benign
0.056
N
LIST_S2
Uncertain
0.94
D;D;D;D
M_CAP
Benign
0.052
D
MetaRNN
Benign
0.0078
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.7
L;.;L;L
PhyloP100
-0.65
PrimateAI
Uncertain
0.71
T
PROVEAN
Uncertain
-3.1
D;.;D;D
REVEL
Benign
0.084
Sift
Benign
0.047
D;.;D;D
Sift4G
Uncertain
0.0060
D;D;D;D
Polyphen
1.0
D;.;D;.
Vest4
0.097
MutPred
0.69
Loss of MoRF binding (P = 0.0812);Loss of MoRF binding (P = 0.0812);Loss of MoRF binding (P = 0.0812);Loss of MoRF binding (P = 0.0812);
MVP
0.35
MPC
0.13
ClinPred
0.15
T
GERP RS
-0.55
PromoterAI
-0.041
Neutral
Varity_R
0.17
gMVP
0.30
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs559143316; hg19: chr17-29298215; API